IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity.
作者信息
Fraussen Judith
机构信息
Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Belgium.
出版信息
EBioMedicine. 2022 Mar;77:103922. doi: 10.1016/j.ebiom.2022.103922. Epub 2022 Mar 5.
Abstract
摘要
相似文献
1
IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity.新型冠状病毒2疫苗接种后的IgM反应：对保护性免疫和既往免疫的见解
EBioMedicine. 2022 Mar;77:103922. doi: 10.1016/j.ebiom.2022.103922. Epub 2022 Mar 5.
2
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
3
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.基于 COVID-19 患者队列的 SARS-CoV-2 抗体的长期动力学和灭活疫苗对 SARS-CoV-2 抗体的影响。
Front Immunol. 2022 Jan 27;13:829665. doi: 10.3389/fimmu.2022.829665. eCollection 2022.
4
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
5
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.新冠病毒（SARS-CoV-2）感染发生在完全接种疫苗很长时间后，与中和抗体缺乏有关。
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115565. doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.
6
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.细菌黏膜免疫疗法 MV130 可预防 SARS-CoV-2 感染并提高 COVID-19 疫苗的免疫原性。
Front Immunol. 2021 Nov 18;12:748103. doi: 10.3389/fimmu.2021.748103. eCollection 2021.
7
Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.使用唾液 IgG 评估养老院居民对 SARS-CoV-2 的免疫力。
J Am Geriatr Soc. 2022 Mar;70(3):659-668. doi: 10.1111/jgs.17660. Epub 2022 Jan 22.
8
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
9
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.单次接种基于 chimpanzee 腺病毒的疫苗可诱导针对 SARS-CoV-2 感染的持续和保护性免疫。
Front Immunol. 2021 Jun 28;12:697074. doi: 10.3389/fimmu.2021.697074. eCollection 2021.
10
Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.日本对 BNT162b2 疫苗的抗体反应：通过测量针对 SARS-CoV-2 受体结合域的 IgG 抗体来监测疫苗效力。
Microbiol Spectr. 2022 Feb 23;10(1):e0118121. doi: 10.1128/spectrum.01181-21. Epub 2022 Jan 19.
引用本文的文献
1
Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza.评估一种用于新冠肺炎和流感的鼻内微粒联合疫苗的免疫原性。
Vaccines (Basel). 2025 Mar 7;13(3):282. doi: 10.3390/vaccines13030282.
2
Immunogenicity of culture filtrated proteins and whole-cell killed formalin of to induced cellular immune response .培养滤液蛋白和全细胞福尔马林灭活物的免疫原性以诱导细胞免疫反应。 （原句表述不太准确规范，可能影响理解，大致意思如上翻译）
Open Vet J. 2024 Dec;14(12):3581-3598. doi: 10.5455/OVJ.2024.v14.i12.40. Epub 2024 Dec 31.
3
Reproducibility Assessment of Enzyme-Linked Immunosorbent Assays to Detect Anti-HPV16 L1-Specific IgG1, IgG3, IgA, and IgM Antibodies.用于检测抗人乳头瘤病毒16型L1特异性IgG1、IgG3、IgA和IgM抗体的酶联免疫吸附测定的重现性评估
Vaccines (Basel). 2024 Sep 27;12(10):1108. doi: 10.3390/vaccines12101108.
4
Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors.通过对献血者血液中抗 SARS-CoV-2 IgG/IgM 抗体的血清阳性率分析来评估厄瓜多尔的 COVID-19 疫情进展。
Front Cell Infect Microbiol. 2024 Jun 21;14:1373450. doi: 10.3389/fcimb.2024.1373450. eCollection 2024.
5
Diverse immune responses in vaccinated individuals with and without symptoms after omicron exposure during the recent outbreak in Guangzhou, China.在近期中国广州疫情期间，奥密克戎暴露后有症状和无症状的接种疫苗个体中的多种免疫反应。
Heliyon. 2024 Jan 10;10(2):e24030. doi: 10.1016/j.heliyon.2024.e24030. eCollection 2024 Jan 30.
6
Inactivated SARS-CoV-2 vaccine candidate immunization on non-human primate animal model: B-cell and T-cell responses immune evaluation.在非人类灵长类动物模型上进行的灭活严重急性呼吸综合征冠状病毒2候选疫苗免疫接种：B细胞和T细胞应答的免疫评估
Heliyon. 2023 Jul 7;9(7):e18039. doi: 10.1016/j.heliyon.2023.e18039. eCollection 2023 Jul.
7
An mRNA-Based Multiple Antigenic Gene Expression System Delivered by Engineered for Severe Fever with Thrombocytopenia Syndrome and Assessment of Its Immunogenicity and Protection Using a Human DC-SIGN-Transduced Mouse Model.一种基于mRNA的多抗原基因表达系统，通过工程化方式递送用于严重发热伴血小板减少综合征，并使用人DC-SIGN转导小鼠模型评估其免疫原性和保护作用。
Pharmaceutics. 2023 Apr 26;15(5):1339. doi: 10.3390/pharmaceutics15051339.
8
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection.接种疫苗后产生 SARS-CoV-2 特异性 IgM 的受试者表现出更长的体液免疫和更低的感染频率。
EBioMedicine. 2023 Mar;89:104471. doi: 10.1016/j.ebiom.2023.104471. Epub 2023 Feb 14.
9
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia.SARS-CoV-2 感染、疫苗接种和成年人抗体反应轨迹：加泰罗尼亚队列研究。
BMC Med. 2022 Sep 16;20(1):347. doi: 10.1186/s12916-022-02547-2.
Zotero 插件